Foreigners and institutional sales marches… Market cap decreased by nearly 2 trillion won in two days
[SK바이오사이언스 홈페이지 캡처. 재판매 및 DB 금지]
(Seoul = Yonhap News) Reporter Kim A-Ram = SK Bioscience closed a sharp decline on the 22nd, the third day of listing.
On this day, in the securities market, SK Bioscience finished trading at 144,000 won, down 13.51% from the previous trading day. It fell for two days in a row following the day before the 1.48% decline ended.
Based on the closing price, the market cap is about 11,160 billion won. Compared to the market capitalization of 12.92 trillion won on the date of listing, it has decreased by 1.91 trillion won in two days.
Foreigners and institutions net sold 21.5 billion won and 1.7 billion won, respectively. However, among institutions, pension funds (200 million won), insurance (500 million won), and investment trust (100 million won) were slightly superior in buying.
Individuals net bought 26.9 billion won and received the sale of foreigners and institutions.
The trend of selling by foreigners and institutions and buying individuals continued for three consecutive days after listing.
As of 3:30 p.m., the trading volume is 45,51,129 shares. The transaction amount was 683.8 billion won, ranking third in both KOSPI and KOSDAQ.
Earlier, on the 18th, SK Bioscience entered the stock market as a ‘dasang’ by jumping up to 169,000 won, which doubled the public offering and added the upper limit.
However, on the 2nd and 3rd days of listing, it fell in succession, and the upper limit march failed.
On this day, SK Chemicals, the major shareholder of SK Bioscience[285130](-5.17%) and preferred stock SK Chemicals[28513K](-6.79%) also ended lower.
Unauthorized reproduction-redistribution prohibited>
2021/03/22 15:47 sent